Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F. Duarte, Anna Sureda, Carmen Canals et al.|Journal of Clinical Oncology|2010Cited by 204
Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant ResearchVikas Gupta, Wael Saber, Adriana K. Malone et al.|Transplantation and Cellular Therapy|2013Cited by 148
The effect of prior exposure to imatinib on transplant-related mortality.Michael W. Deininger, Dietger Niederwieser, Michael Schleuning et al.|PubMed|2006Cited by 114
Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended AnalysisRafael F. Duarte, Peter Dreger, Anna Sureda et al.|Journal of Clinical Oncology|2014Cited by 91
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemiasFranck E. Nicolini, Jörge E. Cortes, Grzegorz Basak et al.|Blood|2011Cited by 61